{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:49:19Z","timestamp":1778759359596,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Science and Technology"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.actbio.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,2,4]],"date-time":"2016-02-04T14:16:30Z","timestamp":1454595390000},"page":"280-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release"],"prefix":"10.1016","volume":"35","author":[{"given":"Cheng-Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun-Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sin-Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsing-Wen","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fwu-Long","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2016.02.005_b0005","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.actbio.2016.02.005_b0010","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.actbio.2016.02.005_b0015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2011.10.027","article-title":"Polypeptide conjugates of D-penicillamine and idarubicin for anticancer therapy","volume":"158","author":"Wadhwa","year":"2012","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2016.02.005_b0020","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bcmd.2011.08.004","article-title":"Disulfiram\/copper complex activated JNK\/c-jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells","volume":"47","author":"Xu","year":"2011","journal-title":"Blood Cell Mol. Dis."},{"key":"10.1016\/j.actbio.2016.02.005_b0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.actbio.2015.05.010","article-title":"Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells","volume":"23","author":"Zhao","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2016.02.005_b0030","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/bm501258s","article-title":"Photochemically triggered cytosolic drug delivery using pH-responsive hyaluronic acid nanoparticles for light-induced cancer therapy","volume":"15","author":"Lee","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2016.02.005_b0035","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1021\/nn5063613","article-title":"A yolk-like multifunctional platform for multimodal imaging and synergistic therapy triggered by a single near-infrared light","volume":"9","author":"Lv","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.actbio.2016.02.005_b0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biomaterials.2015.05.016","article-title":"An imaging-guided platform for synergistic photodynamic\/photothermal\/chemo-therapy with pH\/temperature-responsive drug release","volume":"63","author":"Lv","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.02.005_b0045","doi-asserted-by":"crossref","first-page":"14799","DOI":"10.1039\/C4NR04336G","article-title":"LaF3:Ln mesoporous spheres: controllable synthesis, tunable luminescence and application for dual-modal chemo-\/photo-thermal therapy","volume":"6","author":"Lv","year":"2014","journal-title":"Nanoscale"},{"key":"10.1016\/j.actbio.2016.02.005_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2014.11.019","article-title":"Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance","volume":"198","author":"Yhee","year":"2015","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2016.02.005_b0055","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1016\/j.actbio.2013.04.009","article-title":"Nanoparticle-induced tight-junction opening for the transport of an anti-angiogenic sulfated polysaccharide across Caco-2 cell monolayers","volume":"9","author":"Yu","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2016.02.005_b0060","doi-asserted-by":"crossref","first-page":"18275","DOI":"10.1021\/am505441p","article-title":"FRET-based dual-emission and pH-responsive nanocarriers for enhanced delivery of protein across intestinal epithelial cell barrier","volume":"6","author":"Lu","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.actbio.2016.02.005_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1004","article-title":"CD44: from adhesion molecules to signalling regulators","volume":"4","author":"Ponta","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.actbio.2016.02.005_b0070","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1016\/j.biomaterials.2013.03.050","article-title":"Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery","volume":"34","author":"Yoon","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.02.005_b0075","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7150\/thno.10804","article-title":"Coating solid lipid nanoparticles with hyaluronic acid enhances antitumor activity against melanoma stem-like cells","volume":"5","author":"Shen","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2016.02.005_b0080","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biomaterials.2015.03.006","article-title":"Co-delivery of paclitaxel and gemcitabine via CD44-targeting nanocarriers as a prodrug with synergistic antitumor activity against human biliary cancer","volume":"53","author":"Noh","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.02.005_b0085","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.biomaterials.2013.09.089","article-title":"Biodegradable self-assembled nanoparticles of poly (D, L-lactide-co-glycolide)\/hyaluronic acid block copolymers for target delivery of docetaxel to breast cancer","volume":"35","author":"Huang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.02.005_b0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jconrel.2013.09.008","article-title":"Bioreducible hyaluronic acid conjugates as siRNA carrier for tumor targeting","volume":"172","author":"Yoon","year":"2013","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2016.02.005_b0095","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.actbio.2013.12.025","article-title":"Self-assembled pH-responsive hyaluronic acid-g-poly(L-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin","volume":"10","author":"Qiu","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2016.02.005_b0100","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1016\/j.biomaterials.2014.02.006","article-title":"Hyaluronic acid-chitosan nanoparticles for co-delivery of M1R-34a and doxorubicin in therapy against triple negative breast cancer","volume":"35","author":"Deng","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.02.005_b0105","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1016\/j.biomaterials.2013.03.065","article-title":"Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles","volume":"34","author":"Almalik","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.02.005_b0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/bm050867v","article-title":"Degradative action of reactive oxygen species on hyaluronan","volume":"7","author":"Soltes","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2016.02.005_b0115","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/bc800042s","article-title":"Enhanced intracellular delivery of the reactive oxygen species (ROS)-generating copper chelator D-penicillamine via a novel gelatin-D-penicillamine conjugate","volume":"19","author":"Gupte","year":"2008","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.actbio.2016.02.005_b0120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.actbio.2015.01.044","article-title":"Redox-responsive micelles self-assembled from dynamic covalent block copolymers for intracellular drug delivery","volume":"17","author":"Yang","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2016.02.005_b0125","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1021\/bm5017755","article-title":"Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug","volume":"16","author":"Han","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.actbio.2016.02.005_b0130","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0162-0134(99)00044-6","article-title":"H-1 NMR studies of the reactions of copper(I) and copper(II) with D-penicillamine and glutathione","volume":"75","author":"Kato","year":"1999","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.actbio.2016.02.005_b0135","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.freeradbiomed.2007.07.003","article-title":"Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells","volume":"43","author":"Gupte","year":"2007","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.actbio.2016.02.005_b0140","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2012.03.023","article-title":"A thermosensitive liposome prepared with a Cu2+ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy","volume":"161","author":"Tagami","year":"2012","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2016.02.005_b0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.actbio.2014.09.047","article-title":"Balancing the stability and drug release of polymer micelles by the coordination of dual-sensitive cleavable bonds in cross-linked core","volume":"11","author":"Deng","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2016.02.005_b0150","doi-asserted-by":"crossref","first-page":"16918","DOI":"10.1039\/c1jm11639h","article-title":"Self-organized nanoparticles prepared by guanidine- and disulfide-modified chitosan as a gene delivery carrier","volume":"21","author":"Ho","year":"2011","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.actbio.2016.02.005_b0155","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.1016\/j.bmc.2008.05.026","article-title":"Cu(I)-glutathione complex: a potential source of superoxide radicals generation","volume":"16","author":"Speisky","year":"2008","journal-title":"Bioorgan. Med. Chem."},{"key":"10.1016\/j.actbio.2016.02.005_b0160","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1042\/bj3070697","article-title":"Glutathione-mediated transfer of Cu(I) into phytochelatins","volume":"307","author":"Mehra","year":"1995","journal-title":"Biochem. J."},{"key":"10.1016\/j.actbio.2016.02.005_b0165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11243-010-9330-9","article-title":"The Cu(I)-glutathione complex: factors affecting its formation and capacity to generate reactive oxygen species","volume":"35","author":"Aliaga","year":"2010","journal-title":"Transition Metal. Chem."},{"key":"10.1016\/j.actbio.2016.02.005_b0170","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1073\/pnas.93.15.7832","article-title":"Expression of hyaluronidase by tumor cells induces angiogenesis in vivo","volume":"93","author":"Liu","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.actbio.2016.02.005_b0175","article-title":"Hyaluronic acid-based CD44 targeted nanoparticle delivery of combination MDR1 siRNA\/paclitaxel to overcome drug resistance in ovarian cancer","volume":"74","author":"Yang","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.actbio.2016.02.005_b0180","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.nano.2014.02.015","article-title":"CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy","volume":"10","author":"Zhao","year":"2014","journal-title":"Nanomed. Nanotechnol."},{"key":"10.1016\/j.actbio.2016.02.005_b0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/adhm.201400222","article-title":"Degradable hyaluronic acid\/protamine sulfate interpolyelectrolyte complexes as mirna-delivery nanocapsules for triple-negative breast cancer therapy","volume":"4","author":"Wang","year":"2015","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.actbio.2016.02.005_b0190","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biomaterials.2014.10.031","article-title":"Transferrin-mediated fullerenes nanoparticles as Fe2+-dependent drug vehicles for synergistic anti-tumor efficacy","volume":"37","author":"Zhang","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.02.005_b0195","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7150\/thno.10804","article-title":"Coating solid lipid nanoparticles with hyaluronic acid enhances antitumor activity against melanoma stem-like cells","volume":"5","author":"Shen","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.actbio.2016.02.005_b0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2015.08.035","article-title":"Tumor-specific penetrating peptides-functionalized hyaluronic acid-D-\u03b1-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancers","volume":"71","author":"Liang","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2016.02.005_b0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2015.01.012","article-title":"Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts","volume":"205","author":"Zhong","year":"2015","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2016.02.005_b0210","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1021\/acs.molpharmaceut.5b00129","article-title":"Enhance cancer cell recognition and overcome drug resistance using hyaluronic acid and alpha-tocopheryl succinate based multifunctional nanoparticles","volume":"12","author":"Liang","year":"2015","journal-title":"Mol. Pharmaceut."},{"key":"10.1016\/j.actbio.2016.02.005_b0215","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2015.09.010","article-title":"Functionalized biocompatible WO3 nanoparticles for triggered and targeted in vitro and in vivo photothermal therapy","volume":"217","author":"Sharker","year":"2015","journal-title":"J. Control Rel."},{"key":"10.1016\/j.actbio.2016.02.005_b0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2014.10.024","article-title":"Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation","volume":"197","author":"Han","year":"2015","journal-title":"J Control Rel."},{"key":"10.1016\/j.actbio.2016.02.005_b0225","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1016\/j.biomaterials.2010.11.010","article-title":"PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo","volume":"32","author":"Choi","year":"2011","journal-title":"Biomaterials"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116300484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706116300484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:26:11Z","timestamp":1589617571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706116300484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":45,"alternative-id":["S1742706116300484"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2016.02.005","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2016.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}